Longwood Group

Longwood Fund is a leading venture capital firm based in Boston that specializes in founding, managing, and building innovative life science companies. The firm is unique in its approach, often taking an active role in the day-to-day management of its portfolio companies during their early stages. Longwood has been instrumental in the creation of several high-profile biotech entities, including Vertex Pharmaceuticals, Alnylam Pharmaceuticals, and Momenta Pharmaceuticals. Their investment strategy focuses on transformative technologies and therapeutic platforms that address significant unmet medical needs. By leveraging a deep network of industry experts and academic collaborators, Longwood Fund continues to drive the development of next-generation medicines.